Status:
COMPLETED
Clinical Outcomes of Endoscopic Resection for Treating WHYX Lesion
Lead Sponsor:
Samsung Medical Center
Conditions:
WHYX Lesion
Extremely Well Differentiated Intestinal-type Adenocarcinoma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Endoscopically, WHYX cancers demonstrated a vague extent of tumor spread due to pale color changes in both the background atrophic and metaplastic gastric mucosa. However, the clinical outcomes of WHY...
Eligibility Criteria
Inclusion
- From January 2009 to December 2010 enrolled 872 patients with EGC
Exclusion
- EGC with regional lymph node metastasis in radiologic finding endoscopically suspicious submucosal invasion
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
872 Patients enrolled
Trial Details
Trial ID
NCT01451034
Start Date
January 1 2009
End Date
December 1 2010
Last Update
October 13 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710